期刊文献+

120例慢性丙型肝炎患者生存质量及中医证型研究

Research on Quality of Life and TCM Syndrome Types in 120 Patients with Chronic Hepatitis C
下载PDF
导出
摘要 目的:探讨慢性丙型肝炎患者的生存质量及其与中医证型之间的关系。方法:采用健康状况调查问卷(SF-36)调查慢性丙型肝炎患者生存质量并与健康人作对照,并收集记录慢性丙型肝炎患者的一般资料、中医证候。结果:慢性丙型肝炎患者生存质量各维度的得分显著低于健康人,生存质量某些维度的得分与性别、年龄、学历及病程有一定相关性,且与中医证型密切相关。结论:慢性丙型肝炎患者生存质量显著降低,生存质量各维度受不同中医证型的影响较显著。 Objective:To explore the quality of life(QOL)of patients with chronic hepatitis C and its relationship with the syndrome types differentiated by traditional Chinese medicine.Methods:The QOL in patients was investigated with Short Form-36 questionnaire(SF-36)and compared with that of healthy subjects for control;the common informations and the TCM syndrome types were collected at the same time.Results:The score of all the domains of QOL was respectively lower in the CHC patients than that in the healthy subjects.The score of some domains of QOL showed correlation with gender,age,educational backgroud and course of disease,and correlated with TCM syndrome types closely.Conclusion:QOL of CHC patients significantly decreased.The variation of syndrome types could significantly influence some domains of QOL.
机构地区 江苏省中医院
出处 《辽宁中医药大学学报》 CAS 2012年第9期99-101,共3页 Journal of Liaoning University of Traditional Chinese Medicine
基金 江苏省"六大人才高峰"资助项目第五批
关键词 慢性 丙型 肝炎 生存质量 中医证型 chronic type C hepatitis quality of life TCM syndrome type
  • 相关文献

参考文献7

二级参考文献26

  • 1金实,陈全良,辻井正,武内俊彦.丙型和乙型慢性肝炎的临床表现及中医辨证的比较研究[J].中医杂志,1994,35(9):538-540. 被引量:26
  • 2陈和年.生存质量测量的方法学研究及其应用[J].中国学术期刊文献,1996,2(7):114-114.
  • 3上海中医药大学附属曙光医院肝病科.全国第九届肝胆病学术会议论文集[M].,2000.17.
  • 4Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 5Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 6Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 7Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 8Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 9Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 10Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.

共引文献1288

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部